Episode Details

Back to Episodes
Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions

Published 2 months, 1 week ago
Description
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patients with RA initiating b/tsDMARDS, and the evolution of JAKi prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us